edoc

Uridine supplementation in the treatment of HIV lipoatrophy : results of ACTG 5229

McComsey Grace, A. and Walker, Ulrich A. and Budhathoki Chakra, B. and Su, Zhaohui and Currier, Judith S. and Kosmiski, Lisa and Naini, Linda G. and Charles, Stéphannie and Medvik, Kathy and Aberg, Judith A.. (2010) Uridine supplementation in the treatment of HIV lipoatrophy : results of ACTG 5229. AIDS, Vol. 24, H. 6. pp. 2507-2515.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6006422

Downloads: Statistics Overview

Abstract

Lipoatrophy is prevalent on thymidine nucleoside reverse transcriptase inhibitors (tNRTIs). A pilot trial showed that uridine (NucleomaxX) increased limb fat.
Faculties and Departments:03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Rheumatologie
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Rheumatologie
UniBasel Contributors:Walker, Ulrich A.
Item Type:Article, refereed
Article Subtype:Research Article
Bibsysno:Link to catalogue
Publisher:Current Science
ISSN:0269-9370
Note:Publication type according to Uni Basel Research Database: Journal article
Related URLs:
Identification Number:
Last Modified:21 Jun 2013 12:29
Deposited On:21 Jun 2013 12:28

Repository Staff Only: item control page